<DOC>
	<DOCNO>NCT00466180</DOCNO>
	<brief_summary>Taking antiretrovirals once-a-day consider simpler way improve adherence . However , know assertion apply patient take medication twice-a-day change once-a-day . We hypothesize once-daily dose improves adherence .</brief_summary>
	<brief_title>Adherence , Efficacy Tolerance Once-a-day Nevirapine-based Regimen HIV-1 Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>HIV1 infect adult receive antiretroviral therapy include nevirapine twiceaday least 6 month plasma HIV RNA &lt; 400 cp/ml previous 4 month 2 occasion accept adherence electronic monitoring write informed consent sign asparate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &gt; 2.5N hepatitis virus B C negative AST ALT &gt; 1.25N hepatitis virus B C positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Once-a-day</keyword>
	<keyword>Adherence</keyword>
	<keyword>Nevirapine</keyword>
	<keyword>Patient noncompliance</keyword>
	<keyword>Administration dosage</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>